Microsoft word - publikationsliste_priv.-doz. dr. ickenstein_1995-2012
PUBLIKATIONEN Priv.-Doz. Dr. med. Guntram W. Ickenstein 1995 - 2012 Originalarbeiten:
Muders F, Friedrich E, Luchner A, Pfeifer M, Ickenstein GW, Hamelbeck B, Riegger G, Elsner D Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits
Muders F, Luchner A, Friedrich E, Ickenstein GW, Riegger G, Elsner D Modulation of renal blood flow by endogenous endothelin-1 in conscious rabbits with left ventricular dysfunction Am. J. Hypertens. 1999, 12, 835 –838
Muders F, Neubauer S, Luchner A, Fredersdorf S, Ickenstein GW, Riegger GA, Horn M, Elsner D. Alterations in myocardial creatine kinase (CK) and lactate dehydrogenase (LDH) isoenzyme-distribution in a model of left ventricular dysfunction Ickenstein GW, Klotz JM, Langohr HD Seizures after application of local anesthetics
Dtsch. Zahnärztl. Z 1998 , 5: 337 –339
Ickenstein GW, Klotz JM, Langohr HD Headache caused by polycythemia vera: Classification of a headache under the heading of metabolic disturbances Ickenstein GW, Klotz JM, H.D. Langohr HD Virusencephalitis with parkinsonism, diabetes insipidus and panhypopituitarism
Fortschr. Neurol. Psychiat. 1999, 67: 476 - 481
Reuter U, Salomone S, Ickenstein GW, Waeber C. Effects of chronic sumatriptan and zolmitriptan treatment of 5-HT receptor expression and function in rats Cephalgia 2004, 24(5): 398-407 Ickenstein GW, Kelly PJ, Furie KL, Ambrosi D, Rallis N, Goldstein R, Horick N, Stein J. Predictors of feeding gastrostomy tube removal in stroke patients with dysphagia J Stroke & Cerebrovas Dis 2003, 12 (4): 169-174
Audebert HJ, Kukla C, v. Clarenau C, Kühn J, Schenkel J, Vatankhah B, Ickenstein GW, Haberl RL, Horn M. Telemedicine for safe and extended thrombolysis in stroke
Vatankhah B, Dittmar MS, Fehm NP, Erban P, Ickenstein GW, Jakob W, Bogdahn U, Horn M Thrombolysis for stroke in the elderly
J Thrombosis Thrombolysis 2005, 20 (1): 25-30
Koch H, Horn M, Bogdahn U, Ickenstein GW The relationship between plasma D-Dimer concentrations in patients and acute ischemic stroke subtypes J Stroke & Cerebrovas Dis 2005, 10 (5): 1-6 Ickenstein GW, Horn M, Schenkel J, Vatankhah B, Bogdahn U, Haberl R, Audebert HJ. The use of Telemedicine in combination with a new Stroke-Code-Box significantly increases t-PA utilization in rural communities Neurocritical Care 2005, 3: 27-32 Ickenstein GW, Stein J, Ambrosi D, Goldstein R, Horn M, Bogdahn U. Predictors of survival after severe dysphagic stroke Ickenstein GW, Goldstein R, Stein J, Henze T, Bogdahn U. Neuronal regeneration after acute stroke with severe neurogenic oropharyngeal dysphagia (NOD): a Kaplan-Meier survival analysis Neurol Rehabil 2005, 11 (5):270-278
Koch HJ, Uyanik G, Bogdahn U, Ickenstein GW Relation between laterality and immune response after acute cerebral ischemia Ickenstein GW, Valaikiene J, Koch H, Hau P, Erban P, Schlachetzki F. Ultrasonic contrast agents in transcranial perfusion sonography (TPS) for follow-up of patients with high grade gliomas. Ickenstein GW, Hennemann B, Sauerbruch S, Luecke K, Haas S, Horn M, Andreesen R, Bogdahn U, Winkler J. Mobilization of CD34+ hematopoietic cells, colony-forming cells and long- term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult Cytotherapy 2008; 3:303-311 Ickenstein GW, Isenmann S, Fiehler J, Gahn G, Schumacher M, Klisch J. Thrombolysis in neuromedicine: bridging concepts for the management of acute brain infarction with occlusion of intracranial vessels Clinical Neuroradiology 2008; 18:88-97 Ickenstein GW. Brain perfusion assessment with ultrasound contrast-burst imaging for high-grade gliomas Imaging & Radiology HIRE 2008; 2:35-36
Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008; 359:1238-1251
Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008; 359:1225-1237
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7:875-884. Ickenstein GW, Hofmayer A, Lindner-Pfleghar B, Pluschinski P, Riecker A, Schelling A, Prosiegel M. Standardisation of diagnostic and therapeutic procedures for neurogenic oropharyngeal dysphagia (NOD).
Neurol & Rehabil 2009; 15 (5):290-300
Ickenstein GW, Hofmayer A, Lindner-Pfleghar B, Pluschinski P, Riecker A, Schelling A, Prosiegel M. Manual for the NOD step-wise concept - Standardisation of diagnostic and therapeutic procedures for neurogenic oropharyngeal dysphagia (NOD).
Neurol & Rehabil 2009; 15 (6): 342-354
Teal P, Davis S, Hacke W, Kaste M, Lyden PD; Modified Randomized Exposure Controlled Trial Study Investigators, Fierus M; Bayer HealthCare AG. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT). Stroke. 2009; 40:3518-3525 Ickenstein GW, Groß S, Tenckhoff D, Hausn P, Becker U, Klisch J, Isenmann S. An Empirical Analysis of the Current Need for Teleneuromedical Care in German Hospitals without Neurology Departments.
International Journal of Telemedicine Applications 2010;1-10
Dengler R, Diener HC, Schwartz A, Grond M, Schumacher H, Machnig T, Eschenfelder CC, Leonard J, Weissenborn K, Kastrup A, Haberl R; EARLY Investigators. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded- endpoint trial. Lancet Neurol. 2010; 9:159-66 Ickenstein GW, Riecker A, Höhlig C, Müller R, Becker U, Reichmann H, Prosiegel M. Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dyspahgia (NOD) in stroke and a new NOD step-wise concept. J Neurology 2010; 257:1492-1501
Harrer JU, Valaikiene J, Koch H, Knorr R, Horn M, Ickenstein G, Bogdahn U, Schlachetzki F. Transcranial perfusion sonography using a low mechanical index and pulse inversion harmonic imaging: reliability, inter-
/intraobserver variability. Ultraschall Med. 2011; 32:95-101
Ickenstein GW, Höhlig C, Prosiegel M, Koch H, Dziewas R, Bodechtel U, Müller R, Reichmann H, Riecker A. Prediction of outcome in neurogenic dysphagia within 72 hours of acute stroke.
J Stroke Cerebrovasc Dis 2011, PMID 21683618
Boy S, Sauerbruch S, Kraemer M, Schormann T, Schlachetzki F, Schuierer G, Luerding R, Hennemann B, Orso E, Dabringhaus A, Winkler J, Bogdahn U; RAIS (Regeneration in Acute Ischemic Stroke) Study Group (Collaborators: Ramm P, Ickenstein GW, Haas S, Horn M, Seidl M, Erban P, Vatankhah B, Jakob W, Kaiser B, Villarubia V, May RA, Andreesen R, Schmitz G, Rothe G, Haberl R, Schumacher M, Peschel C). Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe- -results of an open-labeled non randomized phase I/II trial. PLoS One. 2011; 6:epub 23099
Theiss S, Günzel F, Storm A, Hausn P, Isenmann S, Klisch J, Ickenstein GW for the NeuroNet network. Using Routine Data for Quality Assessment in NeuroNet Telestroke Care. J Stroke Cerebrovasc Dis 2012, PMID Buchbeiträge: Ickenstein GW, Jakob W. Hirnödemtherapie:Barbiturate/Hyperventilation In: Kontroversen in der neurologischen Intensivmedizin. Schneider D, Schwab S, Hacke W (Hrsg.) Stuttgart New York. Thieme Verlag 2005 (1): 89-95 Ickenstein GW, Audebert H, Wahlgren NG The implementation of thrombolytic therapy for stroke in routine practice In: Thrombolytic and Antithrombotic Therapy for Stroke. Hacke W,
Bogousslavsky J (Hrsg.). Informa Healthcare 2006 (15): 167-178
Ickenstein GW, Höhlig C Pathogenetische Zusammenhänge und moderne Therapieoptionen der Multiplen Sklerose
In: Multiple Sklerose: Krankheitsbewältigung –Therapiemotivation –Lebensqualität. Twork S, Kugler J (Hrsg.). Springer Verlag 2006 (1): 1-28
EVALUATION AND DESIGN OF DEPENDABLE SYSTEMS WITH DESIGN DIVERSITY Subhasish Mitra, Nirmal R. Saxena and Edward J. McCluskeyDepartments of Electrical Engineering and Computer ScienceStanford University, Stanford, California Abstract Design diversity was described in the past as a Design diversity has long been used to protect technique to avoid or tolerate CMFs in redundant redundant sys
DR. MASOOD & SONS 4 / 8, MUHAMMAD RAF1 STREET, MUHAMMAD NAGAR LAHORE - 54000 STOCKIST AND SOLE DISTRIBUTOR FOR HOMOEOPATHIC STORES AND HOSPITAL PHONE: 36302360, 36364371 FAX: 042-36361138, Email: [email protected] CURRENT PRICE SCHEDULE FOR HOMOEOPATHIC AND BIOCHEMIC MEDICINES,HOMOEOPATHIC DILUTIONS, PILLS AND TABLETS WITH EFFECT FROM 15/12/2011 HOMOEOPATHIC DILUTIONS POTE
